Physician profile
Jared J Patterson
NPI 1508897018
$4,598.96
in general payments reported to CMS, 2019-2025
20 companies · $682 in 2025
The $682 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,417 · 2021: $177 · 2022: $305 · 2023: $262 · 2024: $756 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,245.11 | 2019 | |
| Orthalign INC | $621.66 | 2024-2025 | Orthalign Plus |
| Sanara Medtech INC. | $337.37 | 2024-2025 | Celleraterx, Biasurge, Celleraterx |
| Depuy Synthes Sales INC. | $335.82 | 2019-2023 | Attune |
| Zimmer Biomet Holdings, INC. | $279.74 | 2022-2023 | Rosa |
| Smith+Nephew, INC. | $157.91 | 2021 | |
| Biocomposites INC | $154.90 | 2024-2025 | Stimulan |
| Innovation Technologies INC | $118.23 | 2025 | Irrisept |
| Pfizer INC. | $115.91 | 2021-2024 | |
| Bioventus LLC | $35.61 | 2024-2025 | Durolane, Gelsyn-3 |
| Boston Scientific Corporation | $32.00 | 2024 | |
| Orthofix Medical, INC. | $23.95 | 2019 | |
| Abbott Laboratories | $23.11 | 2024 | Eterna |
| Ferring Pharmaceuticals INC. | $22.03 | 2024 | Euflexxa |
| Medtronic, INC. | $22.02 | 2023 | Kyphon Express II Kyphopak Tray |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $20.61 | 2024 | Ha Minuteman G3-R |
| Avanos Medical | $18.26 | 2024 | Trivisc Sodium Hyaluronate |
| Pacira Therapeutics, INC. | $12.15 | 2019 | |
| Endo Pharmaceuticals INC. | $11.72 | 2019 | |
| Mml US, INC. | $10.85 | 2024 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.